Unknown statusInterventionalPhase 4Last updated Jun 4, 2010

Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis

Effect of Betablocker or Aldosterone Antagonist Therapy on Oxygenation, Peripheral and Cardiac Hemodynamics and Humoral Systems

Overview

ClinicalTrials.gov ID: NCT00332904
Lead Sponsor: Hvidovre University HospitalOTHER
Brief Summary: The study´s purpose is to investigate the effect of beta blockade or aldosterone antagonist therapy on oxygenation, peripheral and cardiac hemodynamics and humoral systems, in patients with liver cirrhosis.
Study Type: Interventional

Status

Overall Status: Unknown status
Start Date: Aug 2006
Primary Completion Date: Jul 2008Actual
Completion Date: Dec 2010Estimated

Study Record Dates

First Submitted: May 31, 2006
First Submitted that Met QC Criteria: May 31, 2006
First Posted: Jun 2, 2006Estimated
Last Update Submitted that Met QC Criteria: Jun 3, 2010
Last Update Posted: Jun 4, 2010Estimated
Last Verified: Jun 2010

NCT00188045Terminated

Hemodynamic Effects of Chronic Administration of Spironolactone and/or Propranolol in Alcoholic Cirrhotic Patients

NCT01059396Completed

Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal

NCT02163512Completed

Effect of Beta-adrenergic Blockers on Cardiac Function, Systemic and Splanchnic Haemodynamic and Kidney Function in Cirrhotic Patiets With Refractory Ascites

NCT02907749Completed

Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in Cirrhosis

NCT03776955Unknown status

Beta-blockers for Oesophageal Varices

NCT03438916Completed

MRI to Assess the Effect of Non-selective Beta-blocker in Patients With Cirrhosis